| Filed On | Filing |
|---|---|
| 02 Oct 2026 |
Form 4: Houvras Yariv, CHIEF MEDICAL OFFICER
Granted 105,000 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 3: Houvras Yariv, CHIEF MEDICAL OFFICER
No securities owned |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 | S-8 |
| 12 Aug 2026 | 10-Q |
| 12 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 12 Jun 2026 |
Form 4: Shannon James Samuel, Director
Granted 5,000 Stock Option (right to buy) |
| 12 Jun 2026 |
Form 4: Bello Akintunde Olatokumbo, Director
Granted 5,000 Stock Option (right to buy) |
| 12 Jun 2026 |
Form 4: Curran Daniel J., Director
Granted 5,000 Stock Option (right to buy) |
| 12 Jun 2026 |
Form 4: Xu Yuan, Director
Granted 5,000 Stock Option (right to buy) |
| 12 Jun 2026 |
Form 4: Ross Robert W., Director
Granted 5,000 Stock Option (right to buy) |
| 12 Jun 2026 |
Form 4: Bonstein Sara, Director
Granted 5,000 Stock Option (right to buy) |
| 12 Jun 2026 |
Form 4: Brennan Aoife, Director
Granted 5,000 Stock Option (right to buy) |
| 12 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders |
| 29 May 2026 | EFFECT |
| 27 May 2026 | CORRESP |
| 27 May 2026 | S-3/A |
| 18 May 2026 | UPLOAD |
| 15 May 2026 | SCHEDULE 13G |
| 15 May 2026 | SCHEDULE 13G/A |
Loading...
